Rebounding from a costly contract dispute with a former partner, layoffs and the death of its then-CEO, Isis Biopolymer has launched its first commercial product, a transdermal patch to reduce facial wrinkles. Here a production worker at the company’s Providence production facility inspects screen prints of the patch. More
This item is available in full to subscribers. If you are a current subscriber, log in to continue.